Navigation Links
Maxygen Announces Hold on MAXY-alpha Development Program
Date:9/21/2007

REDWOOD CITY, Calif., Sept. 21 /PRNewswire-FirstCall/ -- Roche has advised Maxygen, Inc. (Nasdaq: MAXY) that it has voluntarily placed a hold on further clinical development of MAXY-alpha, also known as R7025. MAXY-alpha is a novel interferon-alpha for the treatment of Hepatitis C and Hepatitis B virus infections and is licensed to Roche.

Preliminary observations from a Phase I trial indicate that an unexpected reduction of the pharmacodynamic and pharmacokinetic effects of MAXY-alpha occurred in the majority of subjects who received two doses of MAXY-alpha. In addition, antibodies binding to MAXY-alpha were identified in some subjects. Roche has initiated additional investigational studies in order to assess these results.

"We are all surprised by these unexpected findings," said Russell Howard, Maxygen's chief executive officer. "We don't yet know how this will impact the future timing or advancement of the program. Roche has now started additional work to assess the meaning and significance of these results. We will provide an update once all relevant information is collected and evaluated."

About the Maxygen and Roche Agreement

Maxygen and Roche entered into an agreement in 2003 to develop novel interferon alpha and beta products for a wide range of indications. Roche licensed from Maxygen worldwide commercialization rights to specific novel interferon product candidates for the treatment of Hepatitis C and B virus infections. Maxygen received an initial payment, full research and development funding for work done by Maxygen in the first two years of the collaboration, and milestone payments for the advancement of the MAXY-alpha product candidate. In addition, Maxygen is eligible to receive
'/>"/>

SOURCE Maxygen, Inc
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2008)...LTHAM, Mass., Dec. 2 Decision Biom...ker analysis systems for pharmaceutical research,...a Scientific Advisory Board,consisting of interna...,forefront of biomarker and clinical research. Th... Daniel W. Chan, Ph.D., Director of the Center for...
(Date:12/2/2008)...AHA, Neb. and HOUSTON, Dec. 2 /PRNewswire-FirstCal...O) and Power3 Medical Products, Inc. (OTC,Bulleti...as signed a letter of,intent to acquire exclusive...omarkers, which include NuroPro(R), a proposed dia... Transgenomic plans to offer NuroPro(R) in its,CL...
(Date:12/2/2008)...OTTSDALE, Ariz., Dec. 2 MedPredict...ical competitive intelligence and market,research...rategic insight for,pharma and biotech companies ...e (PD) therapies. This report, entitled Thought L...se, is based on 9 interviews conducted with PD,ex...
(Date:12/2/2008)...LENCIA, Calif., Dec. 2 The Alfred ...MFBE), a philanthropic organization created by,bi...ased commercialization-,enablement institutes at ...cal,product development for the benefit of societ...p://www.mannfbe.org ). , Features of the we...
Breaking Biology Technology:Decision Biomarkers Inc Announces Formation of Scientific Advisory Board 2Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 2Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 3Transgenomic Signs Letter of Intent for an Agreement to Exclusive License With Option to Acquire Power3 Medical Products' Neurodegenerative Diagnostics 4New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinson's Disease Drug Development 2Alfred Mann Foundation for Biomedical Engineering Launches New Web Site Designed to Help University Researchers Bring Biomedical Advances to Market 2
..., , , Katrin Ravenschlag , M...usstr.1, 28359 Germany , Phone: ++49-421-20...i-bremen.de , , Introduction ,...r sediments always results , in coextract...r other , humic substances, which negativ...
..., , , Christian Rohrer and Lars-Erik Pe...any , Lars-Erik Peters, Eppendorf 5Prime, U...e reliability of a PCR* experiment is dependent on...ducibility. An essential prerequisite for a succes...n, as well as thermal cyclers with excellent , ...
..., , , Multiporator , , , ,... Transfection Protocol , Protocol No...., , , , , , , , ... human leukemic monoblasts, , ,...d pEGFP-N1 (in bidistilled H 2 O), , ...
..., , , Multiporator / Electroporator 251..., , Transformation Protocol ,..., , , , , , , ,...croorganism , Staphylococcus epidermidi..., Bacteria, gram positive, , ...
Other Biology Technology:The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 2The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 3The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 4The Use of MasterTaq Polymerase for PCR with Humic Material-Contaminated , DNA 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 2Efficient and Reliable PCR Setup Using Eppendorf MasterMix 3Efficient and Reliable PCR Setup Using Eppendorf MasterMix 4Efficient and Reliable PCR Setup Using Eppendorf MasterMix 5Efficient and Reliable PCR Setup Using Eppendorf MasterMix 6Efficient and Reliable PCR Setup Using Eppendorf MasterMix 7U937 2Staphylococcus epidermidis 2
(Date:12/2/2008)...ber 16, 2008 In a study in the advance online edi... researchers from Albert Einstein College of Medic...ly at a fundamental step of a cell,s life a gene,...ue could provide a window into the process by whic...isease. , The new technique provides a detailed...
(Date:12/2/2008)... release is available in French . , Plant r...ty of California, Berkeley, have announced a major...igenetics. They have demonstrated for the first ti...cing in plants. , The findings are important to... in the continuing quest to breed enhanced crops t...
(Date:12/2/2008)...ST LAFAYETTE, Ind. - Researchers at Purdue Univers...nd holograms to precisely position numerous tiny p...new tool to analyze biological samples or create d...ed rapid electrokinetic patterning, is a potential...patterns can be more quickly and easily changed, s...
(Date:12/2/2008)...ON, Dec. 2, 2008 Scientists and engineers from tw... energy will come together Dec. 8, along with aca...re synergies in moving oil and pumping blood. ,...rt must pump blood through the body. Both systems...els), free of blockages or corrosion, to function ...
Breaking Biology News(10 mins):Einstein researchers develop technique to count messages made by single genes 2Plants display 'molecular amnesia' 2Plants display 'molecular amnesia' 3New holographic method could be used for lab-on-a-chip technologies 2New holographic method could be used for lab-on-a-chip technologies 3New holographic method could be used for lab-on-a-chip technologies 4Using the other guy's toolkit: Similarities of pumping blood, oil examined 2Pharmion Corporation to Announce Third Quarter 2007 Financial Results 1357 1Pharmion Corporation to Announce Third Quarter 2007 Financial Results 1357 2Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 1Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 2Masimo to Report Third Quarter 2007 Financial Results on October 30 2007 1354 3Telik Announces Presentation of Preclinical Data on Dual Inhibitors of Aurora Kinases and VEGFR2 572 1Congressional failure to override SCHIP veto saddens physicians 4098 1Congressional failure to override SCHIP veto saddens physicians 4098 2
...approach animals in the wild more easily from a ca...tor" tuned to the visual movements of an approachi...logist Niko Troje. , "We believe this visual filt...are propelled by the motion of their feet and the ...arch Chair in Vision and Behavioural Sciences. ,...
...h at the University of Illinois atUrbana-Champaign...irst sequence of the swine genome to be completed ... the U.S. Department of Agriculture announced toda... , Lawrence B. Schook, a professor of animal scien...al Swine Genome Sequencing Consortium, will head t...
...stainable agricultural production, what is require...es to the nitrates that predominate in agricultura...ty. The current use of nitrates as a nitrogenated ...environmental problems such as the contamination o...re are also health problems such as deficiencies i...
... is not associated with an increased risk of cance...ue of the Journal of the National Cancer Institu...breast cancer risk and an increased lung cancer ri...s and smoking habits of the women in the study rat... authors conclude. , Past reports have examined th...
Other Biology News:Animal brains 'hard-wired' to recognize predator's foot movements, Queen's study suggests 2Illinois pig to make history as source of first complete swine genome 2Alternatives to the use of nitrate as a fertiliser 2Alternatives to the use of nitrate as a fertiliser 3Breast implants not associated with cancer risk, study reports 2
Any form, any size, any number of mutageneses. ExonBio provides the best service with double sequecing to make sure the success of the mutagenesis.
Request Info
Makes gels easy to load and track during electrophoresis. 10X concentrate of Bromophenol Blue, glycerol solution.
Epi-Grids™ Colony Grid Templates are easy-to-use griding templates that allow rapid organization of colonies from initial screening plates and for preparing precise master plates.
Biology Products: